Literature DB >> 25759379

Similarities and differences of X and Y chromosome homologous genes, SRY and SOX3, in regulating the renin-angiotensin system promoters.

Fabiano C Araujo1, Amy Milsted2, Ingrid K M Watanabe3, Helen L Del Puerto1, Robson A S Santos4, Jozef Lazar5, Fernando M Reis1, Jeremy W Prokop6.   

Abstract

The renin-angiotensin system (RAS) is subject to sex-specific modulation by hormones and gene products. However, sex differences in the balance between the vasoconstrictor/proliferative ACE/ANG II/AT1 axis, and the vasodilator/antiproliferative ACE2/ANG-(1-7)/MAS axis are poorly known. Data in the rat have suggested the male-specific Y-chromosome gene Sry to contribute to balance between these two axes, but why the testis-determining gene has these functions remains unknown. A combination of in silico genetic/protein comparisons, functional luciferase assays for promoters of the human RAS, and RNA-Seq profiling in rat were used to address if regulation of Sry on the RAS is conserved in the homologous X-chromosome gene, Sox3. Both SRY and SOX3 upregulated the promoter of Angiotensinogen (AGT) and downregulated the promoters of ACE2, AT2, and MAS, likely through overlapping mechanisms. The regulation by both SRY and SOX3 on the MAS promoter indicates a cis regulation through multiple SOX binding sites. The Renin (REN) promoter is upregulated by SRY and downregulated by SOX3, likely through trans and cis mechanisms, respectively. Sry transcripts are found in all analyzed male rat tissues including the kidney, while Sox3 transcripts are found only in the brain and testis, suggesting that the primary tissue for renin production (kidney) can only be regulated by SRY and not SOX3. These results suggest that SRY regulation of the RAS is partially shared with its X-chromosome homolog SOX3, but SRY gained a sex-specific control in the kidney for the rate-limiting step of the RAS, potentially resulting in male-specific blood pressure regulation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Sox3; Sry; hypertension; renin angiotensin system; sex differences

Mesh:

Substances:

Year:  2015        PMID: 25759379      PMCID: PMC4421791          DOI: 10.1152/physiolgenomics.00138.2014

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  70 in total

1.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

2.  The SHR Y chromosome increases cardiovascular, endocrine, and behavioral responses to stress compared to the WKY Y chromosome.

Authors:  Cherec Dickey; Jonathan Toot; Melissa Terwilliger; Rex Payne; Monte Turner; Daniel Ely
Journal:  Physiol Behav       Date:  2012-01-20

3.  The Y chromosome effect on blood pressure in two European populations.

Authors:  Fadi J Charchar; Maciej Tomaszewski; Sandosh Padmanabhan; Beata Lacka; Mark N Upton; Gordon C Inglis; Niall H Anderson; Alex McConnachie; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; John M C Connell; Graham C M Watt; Anna F Dominiczak
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

4.  The Sry3 Y chromosome locus elevates blood pressure and renin-angiotensin system indexes.

Authors:  Daniel Ely; Shannon Boehme; Gail Dunphy; Michael Hart; Frank Chiarappa; Brian Miller; Almir S Martins; Monte Turner; Amy Milsted
Journal:  Gend Med       Date:  2011-04

5.  SRY interacts with and negatively regulates androgen receptor transcriptional activity.

Authors:  X Yuan; M L Lu; T Li; S P Balk
Journal:  J Biol Chem       Date:  2001-10-03       Impact factor: 5.157

6.  Blood pressure in genetically hypertensive rats. Influence of the Y chromosome.

Authors:  A O Davidson; N Schork; B C Jaques; A W Kelman; R G Sutcliffe; J L Reid; A F Dominiczak
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

Review 7.  The renin-angiotensin system meets the hallmarks of cancer.

Authors:  Talia Wegman-Ostrosky; Ernesto Soto-Reyes; Silvia Vidal-Millán; José Sánchez-Corona
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2013-08-09       Impact factor: 1.636

Review 8.  Sex differences in hypertension: contribution of the renin-angiotensin system.

Authors:  Christine Maric-Bilkan; Michaele B Manigrasso
Journal:  Gend Med       Date:  2012-07-12

9.  The hypertensive Y chromosome elevates blood pressure in F11 normotensive rats.

Authors:  D L Ely; H Daneshvar; M E Turner; M L Johnson; R L Salisbury
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

Review 10.  Autoimmune Addison disease: pathophysiology and genetic complexity.

Authors:  Anna L Mitchell; Simon H S Pearce
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

View more
  17 in total

Review 1.  Wnt signaling, a novel pathway regulating blood pressure? State of the art review.

Authors:  Maen D Abou Ziki; Arya Mani
Journal:  Atherosclerosis       Date:  2017-05-04       Impact factor: 5.162

Review 2.  Chromosome Y genetic variants: impact in animal models and on human disease.

Authors:  J W Prokop; C F Deschepper
Journal:  Physiol Genomics       Date:  2015-08-18       Impact factor: 3.107

Review 3.  Sex-specific differences in hypertension and associated cardiovascular disease.

Authors:  Katrina M Mirabito Colafella; Kate M Denton
Journal:  Nat Rev Nephrol       Date:  2018-01-30       Impact factor: 28.314

4.  Characterization of Coding/Noncoding Variants for SHROOM3 in Patients with CKD.

Authors:  Jeremy W Prokop; Nan Cher Yeo; Christian Ottmann; Surya B Chhetri; Kacie L Florus; Emily J Ross; Nadiya Sosonkina; Brian A Link; Barry I Freedman; Candice J Coppola; Chris McDermott-Roe; Seppe Leysen; Lech-Gustav Milroy; Femke A Meijer; Aron M Geurts; Frank J Rauscher; Ryne Ramaker; Michael J Flister; Howard J Jacob; Eric M Mendenhall; Jozef Lazar
Journal:  J Am Soc Nephrol       Date:  2018-02-23       Impact factor: 10.121

5.  SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics.

Authors:  Nicholas Hartog; William Faber; Austin Frisch; Jacob Bauss; Caleb P Bupp; Surender Rajasekaran; Jeremy W Prokop
Journal:  Expert Rev Proteomics       Date:  2021-04-05       Impact factor: 3.940

6.  A genomic atlas of human adrenal and gonad development.

Authors:  Ignacio Del Valle; Federica Buonocore; Andrew J Duncan; Lin Lin; Martino Barenco; Rahul Parnaik; Sonia Shah; Mike Hubank; Dianne Gerrelli; John C Achermann
Journal:  Wellcome Open Res       Date:  2017-04-07

7.  Transcriptome analysis of genes related to gonad differentiation and development in Muscovy ducks.

Authors:  Ding-Ping Bai; Yue Chen; Yu-Qiong Hu; Wen-Feng He; Yu-Zhu Shi; Qin-Ming Fan; Ru-Tang Luo; Ang Li
Journal:  BMC Genomics       Date:  2020-06-26       Impact factor: 3.969

8.  The phenotypic impact of the male-specific region of chromosome-Y in inbred mating: the role of genetic variants and gene duplications in multiple inbred rat strains.

Authors:  Jeremy W Prokop; Shirng-Wern Tsaih; Allison B Faber; Shannon Boehme; Adam C Underwood; Samuel Troyer; Lauren Playl; Amy Milsted; Monte E Turner; Daniel Ely; Almir S Martins; Marek Tutaj; Jozef Lazar; Melinda R Dwinell; Howard J Jacob
Journal:  Biol Sex Differ       Date:  2016-02-03       Impact factor: 5.027

Review 9.  The Y chromosome: a blueprint for men's health?

Authors:  Akhlaq A Maan; James Eales; Artur Akbarov; Joshua Rowland; Xiaoguang Xu; Mark A Jobling; Fadi J Charchar; Maciej Tomaszewski
Journal:  Eur J Hum Genet       Date:  2017-08-30       Impact factor: 4.246

Review 10.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.